The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2024

Filed:

Feb. 18, 2022
Applicants:

Park Therapeutics, Inc., Monmouth Junction, NJ (US);

Enteris Biopharma, Inc, Boonton, NJ (US);

Inventors:

James P. Gilligan, Denville, NJ (US);

George R. Maurer, Bell Mead, NJ (US);

Aniruddha M. Railkar, Ambler, PA (US);

Phillip Bauer, Highland Park, IL (US);

Thomas A. Daggs, Verona, NJ (US);

Paul P. Shields, North Caldwell, NJ (US);

Assignees:

Park Therapeutics, Inc., Monmouth Junction, NJ (US);

Enteris Biopharma, Inc., Boonton, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61K 9/20 (2006.01); A61K 38/23 (2006.01); A61P 19/02 (2006.01); A61P 19/10 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2886 (2013.01); A61K 9/2018 (2013.01); A61K 9/2081 (2013.01); A61K 9/2846 (2013.01); A61K 9/2853 (2013.01); A61K 9/2893 (2013.01); A61K 38/23 (2013.01); A61P 19/02 (2018.01); A61P 19/10 (2018.01); A61K 9/2095 (2013.01);
Abstract

Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.


Find Patent Forward Citations

Loading…